Pediatrix Medical Group, Inc.
Income Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.72B | $3.25B | $3.18B | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $232.2M | $385.9M | $372.6M | $305.9M | $247.5M | $218.2M | $193.5M | $170.4M |
| Operating Income | $248.4M | $454.9M | $571.7M | $557.9M | $513.0M | $452.1M | $389.5M | $355.4M |
| Operating Margin | 14.4% | 14.0% | 18.0% | — | — | — | — | — |
| Interest Expense | $92.9M | $74.6M | $63.1M | $23.1M | $8.9M | $5.4M | $3.2M | $3.6M |
| Pretax Income | $166.2M | $385.7M | $513.8M | $539.7M | $508.6M | $448.4M | $388.2M | $353.2M |
| Income Tax Expense | $44.7M | $80.2M | $189.2M | $204.0M | $191.4M | $167.9M | $147.3M | $135.2M |
| Net Income | $268.6M | $320.4M | $324.9M | $336.3M | $317.3M | $280.5M | $240.9M | $218.0M |
| Net Margin | 15.6% | 9.8% | 10.2% | — | — | — | — | — |
| EPS (Basic) | $2.95 | $3.47 | $3.52 | $3.61 | $3.22 | $2.83 | $2.47 | $2.28 |
| EPS (Diluted) | $2.93 | $3.45 | $3.49 | $3.58 | $3.18 | $2.78 | $2.42 | $2.23 |
| Shares Outstanding (Basic) | 91.1M | 92.4M | 92.4M | 93.1M | 98.6M | 99.1M | 97.4M | 95.4M |
| Shares Outstanding (Diluted) | 91.6M | 93.0M | 93.1M | 94.0M | 99.9M | 101.0M | 99.4M | 97.6M |
| Dividends Per Share | — | — | — | — | — | — | — | — |